• Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • NSCLC
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Pulmonary Arterial Hypertension
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • Type I Diabetes
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Breast Cancer
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

Mobile Healthcare Services Brings Customized COVID-19 Testing to Massachusetts

Article

Mobile Healthcare Services has launched in Massachusetts, offering a variety of customized COVID-19 testing program options and conducting more than 30,000 mobile COVID-19 tests per month to help mitigate the spread of the novel coronavirus.

Mobile Healthcare Services (MHS) has launched in Massachusetts, offering a variety of customized COVID-19 testing program options and conducting more than 30,000 mobile COVID-19 tests per month to help mitigate the spread of the novel coronavirus.

In response to the great need for testing during the pandemic, the MHS team of healthcare experts, in conjunction with a world-class laboratory in Boston, created customized COVID-19 testing programs to meet the needs of a wide range of companies and facilities. MHS offers turnkey solutions to manage the logistics, implementation and operation of a testing program so businesses can focus on their day-to-day operations, according to a release.

Through this initiative, MHS is bridging gaps in healthcare accessibility by providing tools, including policies, procedures, best practices, educational resources for administrative staff, specimen collection services, kits and all the necessary supplies to perform COVID-19 testing.

Registered nurses, EMTs and paramedics in full PPE perform on-site sample collection at any desired location within New England. MHS ensures secure, confidential, online results are available between 24 to 48 hours after testing. MHS also guarantees the cost of their testing solution will be among the lowest PCR COVID-19 testing options on the market and of the highest quality.

"Having mobile COVID-19 testing has been a critical component for our organization to continue to safely offer our essential mental health and human services during this challenging time,” said Noreen Hayes, assistant director of human resources for ServiceNet, in the release. "Partnering with Mobile Healthcare Services eliminates the stress of managing the complexities of a testing program, and we can feel confident that our employees, individuals and families are receiving the highest level of care from an experienced team of healthcare providers."

MHS was created to utilize the unique skillset of EMTs, paramedics and field providers who are accustomed to delivering care on-the-go. By leveraging idle time experienced between ambulance calls, MHS is able to provide much needed care in the convenience and comfort of patients’ homes, workplaces or live-in care facilities.

“Mobile Healthcare Services recognizes that healthcare is changing, and it no longer exists solely within the four walls of hospitals, medical office buildings and clinics,” said Alexandre Theoharidis, President and CEO of Mobile Healthcare Services, in the release. “At MHS, we combine the powerful knowledge and experience of field providers with the latest technology innovations in the market to conquer the last mile in healthcare, and bring care to the patient, which is more important than ever as communities look to mitigate the spread of COVID-19.”

Related Videos
Video 8 - "Gaps in Evidence Generation for Digital Therapeutics"
Video 7 - "Adoption Lessons For Payers"
Video 10 - "Managing Self Care"
Video 3 - "Embracing and Improving Access to Technology Tools"
Video 4 - "Assessing the Cost-Effectiveness of Prescription Digital Therapeutics "
Video 3 - "Harnessing Prescription Drug Therapeutics as Monotherapy and Adjunct Therapy"
Video 8 - "Demographic Differences That Impact Care"
Related Content
© 2024 MJH Life Sciences

All rights reserved.